TrialAnnals of internal medicine2022

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.

ACTIV-3/TICO Bamlanivimab Study Group et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.